{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:35:09Z","timestamp":1793061309415,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xcrm.2026.102947","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:40:55Z","timestamp":1785422455000},"page":"102947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["K\u00f6hlmeier-Degos disease is an interferonopathy characterized by type I and II interferon-driven inflammatory vasculopathy"],"prefix":"10.1016","volume":"7","author":[{"given":"Cornelia D.","family":"Cudrici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Pil","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Rosing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Huffstutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima A.","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella M.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahana","family":"Manohar-Sindhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Schaughency","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarfaraz","family":"Hasni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana J.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi H.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7005-3138","authenticated-orcid":false,"given":"Keisuke","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102947_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/bjd.12642","article-title":"Malignant and benign forms of atrophic papulosis (Kohlmeier-Degos disease): systemic involvement determines the prognosis","volume":"170","author":"Theodoridis","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.xcrm.2026.102947_bib2","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/jdv.18260","article-title":"Atrophic papulosis (K\u00f6hlmeier-Degos disease) revisited: a cross-sectional study on 105 patients","volume":"36","author":"Kaleta","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.xcrm.2026.102947_bib3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/jdv.17311","article-title":"Clinical manifestations and treatment outcomes in degos disease: a systematic review","volume":"35","author":"Kim","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.xcrm.2026.102947_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13023-021-01819-z","article-title":"Clinical and laboratory prognosticators of atrophic papulosis (Degos disease): a systematic review","volume":"16","author":"Lu","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.xcrm.2026.102947_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/1346-8138.14280","article-title":"Malignant atrophic papulosis with motor aphasia and intestinal perforation: A case report and review of published works","volume":"45","author":"Hu","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.xcrm.2026.102947_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00000372-200104000-00006","article-title":"Benign cutaneous Degos' disease: a case report with emphasis on histopathology as papules chronologically evolve","volume":"23","author":"Harvell","year":"2001","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.xcrm.2026.102947_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1172-8-10","article-title":"Malignant atrophic papulosis (K\u00f6hlmeier-Degos disease) - a review","volume":"8","author":"Theodoridis","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.xcrm.2026.102947_bib8","first-page":"2208","article-title":"Small bowel fistulae in Degos' disease: a case report and literature review","volume":"91","author":"Atchabahian","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.xcrm.2026.102947_bib9","doi-asserted-by":"crossref","first-page":"e232759","DOI":"10.1136\/bcr-2019-232759","article-title":"Chronic pleuritis leading to severe pulmonary restriction: a rare complication of Degos disease","volume":"12","author":"Saha","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.xcrm.2026.102947_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13023-022-02322-9","article-title":"Gastrointestinal Kohlmeier-Degos disease: a narrative review","volume":"17","author":"Sattler","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.xcrm.2026.102947_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.910288","article-title":"Degos disease with multiple intestinal perforations: A missed-opportunity case report and literature review","volume":"9","author":"Ai","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.xcrm.2026.102947_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151545","article-title":"Degos disease: A radiological-pathological correlation of the neuroradiological aspects of the disease","volume":"47","author":"Moran","year":"2020","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.xcrm.2026.102947_bib13","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1111\/jdv.17377","article-title":"Atrophic papulosis: the wedge-shaped skin necrosis overlays an active lesion","volume":"35","author":"Zouboulis","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.xcrm.2026.102947_bib14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1309\/AJCP66QIMFARLZKI","article-title":"Degos disease: a C5b-9\/interferon-\u03b1-mediated endotheliopathy syndrome","volume":"135","author":"Magro","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.xcrm.2026.102947_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2022.151943","article-title":"Exploring the pathophysiologic basis of constrictive pericarditis of Kohlmeier Degos disease: A case series and review of the literature","volume":"59","author":"Magro","year":"2022","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.xcrm.2026.102947_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1179\/acb.2008.63.2.007","article-title":"Inefficacy of intravenous immunoglobulins and infliximab in Degos' disease","volume":"63","author":"De Breucker","year":"2008","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.xcrm.2026.102947_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1347587","article-title":"Malignant atrophic papulosis treated with eculizumab and hirudin: a fatal case report and literature review","volume":"11","author":"Yu","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.xcrm.2026.102947_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1750-1172-8-185","article-title":"The effects of Eculizumab on the pathology of malignant atrophic papulosis","volume":"8","author":"Magro","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.xcrm.2026.102947_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome: A consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.xcrm.2026.102947_bib20","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/jid.2009.42","article-title":"Lichenoid tissue reaction\/interface dermatitis: clinical and histological perspectives","volume":"129","author":"Sontheimer","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.xcrm.2026.102947_bib21","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1038\/jid.2008.96","article-title":"An IFN-associated cytotoxic cellular immune response against viral, self-or tumor antigens is a common pathogenetic feature in \u201cinterface dermatitis\u201d","volume":"128","author":"Wenzel","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.xcrm.2026.102947_bib22","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1172\/JCI26322","article-title":"IKK\/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy","volume":"115","author":"Luo","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102947_bib23","doi-asserted-by":"crossref","first-page":"16968","DOI":"10.1074\/jbc.273.27.16968","article-title":"RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase","volume":"273","author":"McCarthy","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2026.102947_bib24","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1084\/jem.20181892","article-title":"Cell death-mediated cytokine release and its therapeutic implications","volume":"216","author":"Place","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2026.102947_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2026.102947_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.physiol.60.1.575","article-title":"The many roles of c-Myc in apoptosis","volume":"60","author":"Thompson","year":"1998","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.xcrm.2026.102947_bib27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1126\/science.281.5379.998","article-title":"IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival","volume":"281","author":"Wu","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102947_bib28","doi-asserted-by":"crossref","first-page":"a022293","DOI":"10.1101\/cshperspect.a022293","article-title":"TGF-\u03b21 Signaling and Tissue Fibrosis","volume":"10","author":"Kim","year":"2018","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.xcrm.2026.102947_bib29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ijcard.2013.04.139","article-title":"The role of thrombospondin-1 in cardiovascular health and pathology","volume":"168","author":"Krishna","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.xcrm.2026.102947_bib30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/ars.2007.1893","article-title":"Intracellular iron transport and storage: from molecular mechanisms to health implications","volume":"10","author":"MacKenzie","year":"2008","journal-title":"Antioxid. Redox Signaling"},{"key":"10.1016\/j.xcrm.2026.102947_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.643435","article-title":"Vascular and Macrophage Heme Oxygenase-1 in Hypertension: A Mini-Review","volume":"12","author":"Mart\u00ednez-Casales","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.xcrm.2026.102947_bib32","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.cell.2020.05.006","article-title":"Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients","volume":"181","author":"Bost","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102947_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/03009749950154248","article-title":"Relationship between CD4+\/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus","volume":"28","author":"Maeda","year":"1999","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.xcrm.2026.102947_bib34","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/s44318-024-00092-7","article-title":"Dynamic control of gene expression by ISGF3 and IRF1 during IFN\u03b2 and IFN\u03b3 signaling","volume":"43","author":"Ravi Sundar Jose Geetha","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2026.102947_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2009.11.021","article-title":"Gene modulation and immunoregulatory roles of interferon gamma","volume":"50","author":"Saha","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.xcrm.2026.102947_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.humpath.2021.08.005","article-title":"Cutaneous eccrine inflammation and necrosis: review of inflammatory disorders affecting the eccrine apparatus including new associations","volume":"118","author":"Shakshouk","year":"2021","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.xcrm.2026.102947_bib37","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41375-020-01018-y","article-title":"Compassionate use of JAK1\/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study","volume":"35","author":"Vannucchi","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2026.102947_bib38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/BF01828450","article-title":"Multiple Hautnekrosen bei Thrombangitis obliterans","volume":"181","author":"Kohlmeier","year":"1941","journal-title":"Arch. Dermatol. Syph."},{"key":"10.1016\/j.xcrm.2026.102947_bib39","first-page":"148","article-title":"Dermatite papulosqameuse atrophiante","volume":"49","author":"Degos","year":"1942","journal-title":"Bull Soc Fr Derm Syph"},{"key":"10.1016\/j.xcrm.2026.102947_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12688\/f1000research.22139.1","article-title":"scRepertoire: An R-based toolkit for single-cell immune receptor analysis","volume":"9","author":"Borcherding","year":"2020","journal-title":"F1000Res."},{"key":"10.1016\/j.xcrm.2026.102947_bib41","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","article-title":"The single-cell transcriptional landscape of mammalian organogenesis","volume":"566","author":"Cao","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102947_bib42","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:23:36Z","timestamp":1793060616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126003642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666379126003642"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102947","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"K\u00f6hlmeier-Degos disease is an interferonopathy characterized by type I and II interferon-driven inflammatory vasculopathy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102947"}}